Next Quarterly Earnings
Pre-market — typically before 3:30 p.m. German time (before the US open at 9:30 a.m. New York time).
Krystal Biotech, a US-based biotechnology company, specializes in the development of innovative gene therapies. Its focus is on rare and severe dermatological diseases. The company leverages advanced technologies to provide much-needed treatments for patients and improve their quality of life. Krystal Biotech is dedicated to research and development in medical biotechnology to advance groundbreaking therapies.
Pre-market — typically before 3:30 p.m. German time (before the US open at 9:30 a.m. New York time).
Krystal Biotech is scheduled to report its next quarterly earnings on 11/09/2026. Pre-market — typically before 3:30 p.m. German time (before the US open at 9:30 a.m. New York time).
Krystal Biotech last reported quarterly earnings on 8/3/2026 (Q2 2026). Earnings per share (EPS) came in at 1.79 USD.
Across its last 3 earnings reports, Krystal Biotech stock moved by ±4.1% on average the following day. The largest reaction was +7.9% on 05/04/2026; 3 of 3 reactions were positive.
Krystal Biotech has beaten analyst EPS estimates in 4 of its last 5 evaluated quarters (beat rate: 80%).
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.
Basis: price reactions to the last 3 report dates (close to close).
Basis: 5 quarters with an analyst estimate and reported EPS.
Past price reactions are not a reliable indicator of future performance.